Dudediligence.

X4 Pharmaceuticals, Inc

XFORNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 2213GPassive stake of 5% or more (13G), filed by Venrock Healthcare Capital Partners III
  2. Sep 88-KOther events8.019.01
  3. Sep 88-KOther events8.019.01
  4. Aug 610-QQuarterly report
  5. Jul 3013GPassive stake of 5% or more (13G), filed by BlackRock
  6. Jul 18-KOfficer or director change and Regulation FD disclosure5.027.019.01
  7. May 138-K/AOfficer or director change and shareholder vote (amended)5.025.079.01
  8. May 128-KOfficer or director change and shareholder vote5.025.07
  9. May 6S-3Shelf registration
  10. May 610-QQuarterly report
  11. Mar 1710-KAnnual report
  12. Nov 5, 202510-QQuarterly report
  13. Nov 5, 20258-KResults of operations2.029.01
  14. Oct 24, 20258-KMaterial agreement1.019.01
  15. Oct 24, 2025424B5Prospectus for an offering
  16. Oct 23, 2025424B5Prospectus for an offering
  17. Sep 18, 2025424B3Prospectus for an offering
  18. Sep 17, 20258-KOfficer or director change and Regulation FD disclosure2.055.027.019.01
  19. Sep 10, 2025S-3Shelf registration
  20. Aug 25, 20258-KOfficer or director change5.02
  21. Aug 13, 20258-KMaterial agreement and unregistered sale of shares1.013.028.019.01
  22. Aug 12, 20258-KMaterial agreement and unregistered sale of shares1.013.025.028.019.01
  23. Aug 8, 202510-QQuarterly report
  24. Jun 23, 20258-KMaterial agreement1.019.01
  25. Jun 23, 2025424B5Prospectus for an offering
  26. Jun 11, 20258-KShareholder vote5.07
  27. May 1, 202510-QQuarterly report
  28. May 1, 20258-KResults of operations and Regulation FD disclosure2.027.01
  29. Apr 24, 20258-KBylaws or fiscal year changed and other events5.038.019.01
  30. Apr 18, 20258-KShareholder vote5.07
  31. Mar 25, 202510-KAnnual report
  32. Mar 25, 20258-KResults of operations2.029.01
  33. Mar 3, 20258-KOther events8.01
  34. Feb 6, 20258-KRegulation FD disclosure and exit or restructuring costs2.057.019.01
  35. Jan 13, 20258-KMaterial agreement and Regulation FD disclosure1.017.019.01
  36. Nov 13, 202410-QQuarterly report
  37. Nov 13, 20248-KRegulation FD disclosure and other events7.018.019.01
  38. Nov 13, 20248-KResults of operations2.029.01